Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial
Pollard, Richard B, MD, Rockstroh, Jürgen K, MD, Pantaleo, Giuseppe, MD, Asmuth, David M, MD, Peters, Barry, MD, Lazzarin, Adriano, Prof, Garcia, Felipe, MD, Ellefsen, Kim, MSc, Podzamczer, Daniel, MD, van Lunzen, Jan, MD, Arastéh, Keikawus, MD, Schürmann, Dirk, MD, Clotet, Bonaventura, MD, Hardy, W David, MD, Mitsuyasu, Ronald, MD, Moyle, Graeme, MD, Plettenberg, Andreas, MD, Fisher, Martin, MD, Fätkenheuer, Gerd, MD, Fischl, Margaret, MD, Taiwo, Babafemi, MD, Baksaas, Ingebjørg, PhD, Jolliffe, Darren, MSc, Persson, Stefan, PhD, Jelmert, Øyvind, MSc, Hovden, Arnt-Ove, PhD, Sommerfelt, Maja A, PhD, Wendel-Hansen, Vidar, Dr, Sørensen, Birger, MSc
Published in The Lancet infectious diseases (01.04.2014)
Published in The Lancet infectious diseases (01.04.2014)
Get full text
Journal Article
Bioavailability of Extended-Release Nevirapine 400 and 300 mg in HIV-1: A Multicenter, Open-Label Study
Battegay, Manuel, MD, Arasteh, Keikawus, MD, Plettenberg, Andreas, MD, Bogner, Johannes R., MD, Livrozet, Jean-Michel, MD, Witt, Mallory D., MD, Mossdorf, Erik, MD, Yong, Chan-Loi, PhD, Zhang, Wei, PhD, Macha, Sreeraj, PhD, Berger, Frank, MD, Stern, Jerry, MD, Robinson, Patrick, MD, Quinson, Anne-Marie, MD
Published in Clinical therapeutics (01.09.2011)
Published in Clinical therapeutics (01.09.2011)
Get full text
Journal Article